These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3849980)

  • 21. Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low dose rather than a high dose of cyclophosphamide.
    Mokyr MB; Dray S
    Cancer Res; 1983 Jul; 43(7):3112-9. PubMed ID: 6850619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depressed natural killer cell activity in tumor-bearing rats: effect of immunotherapy and cytoreductive chemotherapy.
    Stratton JA; Braly PS; Rettenmaier MA; DiSaia PJ
    Clin Immunol Immunopathol; 1983 Aug; 28(2):170-6. PubMed ID: 6683606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumoral and antimetastatic effects of metronomic chemotherapy with cyclophosphamide combined with celecoxib on murine mammary adenocarcinomas.
    Mainetti LE; Rozados VR; Rossa A; Bonfil RD; Scharovsky OG
    J Cancer Res Clin Oncol; 2011 Jan; 137(1):151-63. PubMed ID: 20349084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cyclophosphamide on spleen cell suppressor activity and tumour growth in mice.
    Larsen FS; Spärck JV
    Acta Pathol Microbiol Immunol Scand C; 1983 Oct; 91(5):323-33. PubMed ID: 6229132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased immunogenicity of a spontaneous variant clone of the 13762A rat mammary adenocarcinoma.
    Kreider JW; Bartlett GL
    J Natl Cancer Inst; 1985 Jul; 75(1):141-9. PubMed ID: 3859687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of low-dose cyclophosphamide and immunologic exposure upon growth of established Dunning R-3327-G subline rat prostate adenocarcinomas.
    Rubenstein M; Shaw MW; Bhatti RA; Habibi H; McKiel CF; Guinan PD
    Prostate; 1985; 7(2):151-9. PubMed ID: 4048013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.
    Kuperman O; Fortner GW; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1282-7. PubMed ID: 1176776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system.
    Ben-Eliyahu S; Yirmiya R; Liebeskind JC; Taylor AN; Gale RP
    Brain Behav Immun; 1991 Jun; 5(2):193-205. PubMed ID: 1654166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Active specific immunotherapy with extracted tumor-specific transplantation antigen, cyclophosphamide, and adoptive transfer of tumor-specific cytotoxic T-cell clones.
    Naito K; Pellis NR; Kahan BD
    Cell Immunol; 1988 Jan; 111(1):216-34. PubMed ID: 3257414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists.
    Manrique SZ; Dominguez AL; Mirza N; Spencer CD; Bradley JM; Finke JH; Lee JJ; Pease LR; Gendler SJ; Cohen PA
    Oncotarget; 2016 Jul; 7(28):42919-42942. PubMed ID: 27341020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic adoptive transfer of immunity to 13762A rat mammary adenocarcinoma.
    Boyer CM; Kreider JW; Bartlett GL
    Cancer Res; 1981 Jun; 41(6):2394-400. PubMed ID: 6972251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of combination treatment with cyclophosphamide and nonspecific passive immunization on a transplantable tumor in WKA rats.
    Gotohda E; Kawamura T; Sendo F; Nakayama M; Akiyama J
    Cancer Res; 1976 Jul; 36(7 PT 1):2119-23. PubMed ID: 1277122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic effect of clarithromycin on a transplanted tumor in rats.
    Sassa K; Mizushima Y; Fujishita T; Oosaki R; Kobayashi M
    Antimicrob Agents Chemother; 1999 Jan; 43(1):67-72. PubMed ID: 9869567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ineffectiveness of adoptive chemoimmunotherapy with lymphokine-activated killer cells, interleukin-2, and cyclophosphamide on palpable intradermal murine bladder cancer.
    Lee K; O'Donnell RW; Cockett AT
    J Biol Response Mod; 1988 Feb; 7(1):43-53. PubMed ID: 3259620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular-mass tumor-associated antigens: rate of lymphoid infiltration and distribution of T lymphocytes in tumors.
    Ben-Hur H; Kossoy G; Zandbank J; Zusman I
    Int J Mol Med; 2002 Apr; 9(4):425-30. PubMed ID: 11891540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response to a syngeneic mammary adenocarcinoma. I. Comparison of kinetics of tumor cell growth and cytotoxic responses in syngeneic and allogeneic rats.
    Fortner GW; Kuperman O; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1269-76. PubMed ID: 1080776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is cyclophosphamide self-defeating as an antitumor agents?
    Laursen ML
    J Cancer Res Clin Oncol; 1980; 97(1):87-90. PubMed ID: 7400210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diminution of cyclophosphamide-induced suppression of antitumor immunity by an immunomodulator PS-K and combined therapeutic effects of PS-K and cyclophosphamide on transplanted tumor in rats.
    Mizushima Y; Yuhki N; Hosokawa M; Kobayashi H
    Cancer Res; 1982 Dec; 42(12):5176-80. PubMed ID: 7139621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethanol increases tumor progression in rats: possible involvement of natural killer cells.
    Yirmiya R; Ben-Eliyahu S; Gale RP; Shavit Y; Liebeskind JC; Taylor AN
    Brain Behav Immun; 1992 Mar; 6(1):74-86. PubMed ID: 1571604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct T-cell proliferative responses to 13762A rat mammary adenocarcinoma and derived clones.
    Christensen ND; Kreider JW; Bartlett GL; Horetsky RL
    Cell Immunol; 1986 Feb; 97(2):433-45. PubMed ID: 3091274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.